Low Back Pain, Recurrent: Clinical Trials

4 trials for Low Back Pain, Recurrent, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 completed, 1 terminated. 4 Phase 2, 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 24Completed 3, Terminated 1
Phase 31Completed 1

Follow Low Back Pain, Recurrent: new trials by email Literature Review of Low Back Pain, Recurrent trials Research Report on Low Back Pain, Recurrent

Trials (filtered) newest first · largest first

All 4 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Open-label Placebo in Manual Therapy
Open-label placebo, Osteopathic manipulative treatment - Low Back Pain, Recurrent
Phase 2CompletedStudio Osteopatico Busto Arsizio312024-02-262025-08-11
Effects of Sleep Disruption on Drug Response
Within-Subject test of blinded study medication - Low Back Pain, Recurrent, Healthy
Phase 2CompletedJohns Hopkins University1092019-10-072026-10-21
Optimizing Chronic Low Back Pain Exercise Therapies With Cerebral Electrical Stimulation
Real transcranial direct current stimulation + therapeutic exercises for back pain, Sham transcranial direct current stimulation + therapeutic exercises for back pain - Low Back Pain, Recurrent, Chronic Low Back Pain
Phase 2 / Phase 3CompletedUniversidade Federal do PiauĂ­602018-04-102021-01-19
A Dose-ranging Study of the Safety and Effectiveness of JNJ-42160443 as add-on Treatment in Patients With Low Back Pain
JNJ-42160443 3 mg, JNJ-42160443 1 mg, JNJ-42160443 6 mg/3mg - Low Back Pain, Low Back Pain, Recurrent
Phase 2TerminatedJohnson & Johnson Pharmaceutical Research & Development, L.L.C.3892009-09-012016-06-06

Narrower conditions

Low Back Pain (4)  ·  Chronic Pain (1)

Broader conditions

Back Pain (4)  ·  Neurologic Manifestations (4)  ·  Pain (4)  ·  Pathological Conditions, Signs and Symptoms (4)  ·  Signs and Symptoms (4)

Interventions

Exercise Therapy (1)  ·  Manipulation, Osteopathic (1)  ·  fulranumab (1)

Sponsors

Johns Hopkins University (1)  ·  Johnson & Johnson Pharmaceutical Research & Development, L.L.C. (1)  ·  Studio Osteopatico Busto Arsizio (1)  ·  Universidade Federal do PiauĂ­ (1)

Countries

United States (2)  ·  Belgium (1)  ·  Brazil (1)  ·  Canada (1)  ·  Italy (1)  ·  Netherlands (1)

Top investigators

Fuad A Hazime, PhD (1)  ·  Michael T. Smith, PhD (1)

Results publications

PMID 27101815, PMID 32526017

NIH funding

2009 (1), R01DA048206 (1)